Daiju Ichikawa

608 total citations
35 papers, 494 citations indexed

About

Daiju Ichikawa is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Daiju Ichikawa has authored 35 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Hematology and 11 papers in Immunology. Recurrent topics in Daiju Ichikawa's work include Multiple Myeloma Research and Treatments (10 papers), Protein Degradation and Inhibitors (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Daiju Ichikawa is often cited by papers focused on Multiple Myeloma Research and Treatments (10 papers), Protein Degradation and Inhibitors (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Daiju Ichikawa collaborates with scholars based in Japan, United States and New Zealand. Daiju Ichikawa's co-authors include Yutaka Hattori, Yoshiko Sonoda, Tadashi Kasahara, Kenichi Nagase, Hideko Kanazawa, Richard R. Hardy, Kyoko Hayakawa, Susan A. Shinton, Aya Mizutani Akimoto and Yan Zhou and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Blood.

In The Last Decade

Daiju Ichikawa

34 papers receiving 490 citations

Peers

Countries citing papers authored by Daiju Ichikawa

Since Specialization

Citations

This map shows the geographic impact of Daiju Ichikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daiju Ichikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daiju Ichikawa more than expected).

Fields of papers citing papers by Daiju Ichikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daiju Ichikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daiju Ichikawa. The network helps show where Daiju Ichikawa may publish in the future.

Co-authorship network of co-authors of Daiju Ichikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Daiju Ichikawa. A scholar is included among the top collaborators of Daiju Ichikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daiju Ichikawa. Daiju Ichikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Immunomodulatory Effect of Proteasome Inhibitors via the Induction of Immunogenic Cell Death in Myeloma Cells 2023 ·Pharmaceuticals ·Maiko Matsushita, (unknown), (unknown), (unknown), Makoto Osada, (unknown), Maki Hirao, Daiju Ichikawa, Yutaka Hattori	6
2	GTN057, a komaroviquinone derivative, induced myeloma cells' death in vivo and inhibited c‐MET tyrosine kinase 2023 ·Cancer Medicine ·(unknown), (unknown), Mariko Sato, (unknown), (unknown), Hiromu Sugiyama, Yutaka Suto, Genji Iwasaki, Taketo Yamada, Fumiyuki Kiuchi, Daiju Ichikawa, Maiko Matsushita, Maki Hirao, (unknown), (unknown), Yutaka Hattori	3
3	A thermoresponsive cationic block copolymer brush-grafted silica bead interface for temperature-modulated separation of adipose-derived stem cells 2022 ·Colloids and Surfaces B Biointerfaces ·Kenichi Nagase, (unknown), (unknown), Daiju Ichikawa, Yutaka Hattori, Hideko Kanazawa	19
4	Thermally-modulated cell separation columns using a thermoresponsive block copolymer brush as a packing material for the purification of mesenchymal stem cells 2021 ·Biomaterials Science ·Kenichi Nagase, (unknown), Yuki Nagata, (unknown), Daiju Ichikawa, (unknown), Yutaka Hattori, Hideko Kanazawa	29
5	Endogenous neurotoxin-like protein Ly6H inhibits alpha7 nicotinic acetylcholine receptor currents at the plasma membrane 2020 ·Scientific Reports ·Yasuhiro Moriwaki, (unknown), (unknown), (unknown), (unknown), (unknown), Daiju Ichikawa, Shoutaro Tsuji, Fusao Kato, Hidemi Misawa	10
6	Antibody drug separation using thermoresponsive anionic polymer brush modified beads with optimised electrostatic and hydrophobic interactions 2020 ·Scientific Reports ·Kenichi Nagase, (unknown), Koji Ikeda, (unknown), Daiju Ichikawa, Aya Mizutani Akimoto, Yutaka Hattori, Hideko Kanazawa	46
7	Temperature-modulated cell-separation column using temperature-responsive cationic copolymer hydrogel-modified silica beads 2019 ·Colloids and Surfaces B Biointerfaces ·Kenichi Nagase, (unknown), Daiju Ichikawa, Aya Mizutani Akimoto, Yutaka Hattori, Hideko Kanazawa	30
8	A phenylphthalimide derivative, TC11, induces apoptosis by degrading MCL1 in multiple myeloma cells 2019 ·Biochemical and Biophysical Research Communications ·Daiju Ichikawa, Misa Nakamura, (unknown), (unknown), Maiko Matsushita, Hiroshi Yanagawa, Yutaka Hattori	3
9	Elucidation of the IMiDs-Resistant Mechanism and Development of the Overcoming Drugs Inducing CRBN Independent G2/M Cell Cycle Arrest in Myeloma Cells 2018 ·Blood ·(unknown), (unknown), (unknown), Tomofumi Yamamoto, (unknown), Hiroshi Yanagawa, Daiju Ichikawa, Maiko Matsushita, Yutaka Hattori	1
10	A novel phenylphthalimide derivative, pegylated TC11, improves pharmacokinetic properties and induces apoptosis of high-risk myeloma cells via G2/M cell-cycle arrest 2017 ·Biochemical and Biophysical Research Communications ·(unknown), (unknown), Daiju Ichikawa, (unknown), (unknown), Noriko Tabata, Taketo Yamada, Maiko Matsushita, Takeshi Sugai, Hiroshi Yanagawa, Yutaka Hattori	2
11	CXorf48 is a potential therapeutic target for achieving treatment-free remission in CML patients 2017 ·Blood Cancer Journal ·Maiko Matsushita, Kyoko Ozawa, Takaya Suzuki, Masaru Nakamura, (unknown), (unknown), Daiju Ichikawa, Eri Matsuki, Masatoshi Sakurai, Daiki Karigane, Hidenori Kasahara, Nobuo Tsukamoto, Takayuki Shimizu, Takehiko Mori, Hideaki Nakajima, Shinichiro Okamoto, Yutaka Kawakami, Yutaka Hattori	12
12	Synthesis and biological evaluation of the natural product komaroviquinone and related compounds aiming at a potential therapeutic lead compound for high-risk multiple myeloma 2017 ·Bioorganic & Medicinal Chemistry Letters ·Yutaka Suto, Mariko Sato, (unknown), (unknown), (unknown), Daiju Ichikawa, Maiko Matsushita, Noriyuki Yamagiwa, Genji Iwasaki, Fumiyuki Kiuchi, Yutaka Hattori	8
13	Identification of Novel HLA-A24:02-Restricted Epitope Derived from a Homeobox Protein Expressed in Hematological Malignancies 2016 ·PLoS ONE* ·Maiko Matsushita, (unknown), (unknown), Chiaki Tanaka, (unknown), Koji Ozawa, Takuma Suzuki, Daiju Ichikawa, Hiroyuki Aburatani, Shinichiro Okamoto, Yutaka Kawakami, Yutaka Hattori	5
14	A Novel Phthalimide Derivative, TC11, Has Preclinical Effects on High-Risk Myeloma Cells and Osteoclasts 2015 ·PLoS ONE ·Maiko Matsushita, (unknown), Yuka Hasegawa, (unknown), Noriko Tabata, (unknown), Hiroshi Yanagawa, Tsukasa Oikawa, Koichi Matsuo, Wenlin Du, Taketo Yamada, (unknown), Daiju Ichikawa, Yutaka Hattori	9
15	A myeloma cell line established from a patient refractory to thalidomide therapy revealed high-risk cytogenetic abnormalities and produced vascular endothelial growth factor 2013 ·Blood Cancer Journal ·Yutaka Hattori, Wei Du, Taketo Yamada, Daiju Ichikawa, (unknown), Maiko Matsushita	8
16	GRAIL (Gene Related to Anergy in Lymphocytes) Regulates Cytoskeletal Reorganization through Ubiquitination and Degradation of Arp2/3 Subunit 5 and Coronin 1A 2011 ·Journal of Biological Chemistry ·Daiju Ichikawa, Miho Mizuno, Takashi Yamamura, Sachiko Miyake	19
17	TNF-receptor associated factor 6-deficient fibroblast is sensitive to the TNF-α-induced cell death: Involvement of reactive oxygen species 2006 ·Biochemical and Biophysical Research Communications ·Daiju Ichikawa, Megumi Funakoshi‐Tago, Eriko Aizu-Yokota, Yoshiko Sonoda, Jun‐ichiro Inoue, Tadashi Kasahara	8
18	Focal adhesion kinase determines the fate of death or survival of cells in response to TNFα in the presence of actinomycin D 2006 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Reiko Takahashi, Yoshiko Sonoda, Daiju Ichikawa, Naomi Yoshida, (unknown), Tadashi Kasahara	19
19	Down-regulation of procaspase-8 expression by focal adhesion kinase protects HL-60 cells from TRAIL-induced apoptosis 2004 ·Biochemical and Biophysical Research Communications ·(unknown), Yoshiko Sonoda, (unknown), Daiju Ichikawa, (unknown), Eriko Aizu-Yokota, Tadashi Kasahara	13
20	[Application of monoclonal antibody for drug delivery system--missile therapy for cancer]. 1998 ·PubMed ·Toshiharu Yamaguchi, Takashi Takahashi, Kazuya Kitamura, Eigo Otsuji, Chohei Sakakura, (unknown), Hiroshi Tsuruta, Daiju Ichikawa, Hiroyoshi Matsumura, Keiichi Yamamoto, Tomoki Nishida, Atsuko Kimura	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact